Globus Medical, Inc. (GMED)

Globus Medical Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Globus Medical stock have an average target of 94, with a low estimate of 68 and a high estimate of 115. The average target predicts an increase of 59.30% from the current stock price of 59.01.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$68	$94	$94	$115
Change	+15.23%	+59.30%	+59.30%	+94.88%

Analyst Ratings

The average analyst rating for Globus Medical stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	6	5	4	4	4	4
Buy	5	5	5	5	5	5
Hold	2	3	4	4	4	4
Sell	1	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	13	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $80 → $68	Hold	Maintains	$80 → $68	+15.23%	May 12, 2025
Matt O'Brien Piper Sandler	Piper Sandler	Buy Maintains $100 → $80	Buy	Maintains	$100 → $80	+35.57%	May 9, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $82 → $80	Hold	Maintains	$82 → $80	+35.57%	Apr 11, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $90 → $82	Hold	Maintains	$90 → $82	+38.96%	Mar 18, 2025
David Saxon Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.86B

Increased by 13.36%

from 2.52B

Revenue Next Year

3.09B

Increased by 8.12%

from 2.86B

EPS This Year

3.51

Increased by 367.80%

from 0.75

EPS Next Year

4.01

Increased by 14.29%

from 3.51

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	789.04M	958.10M	1.02B	1.57B	2.52B	2.86B	3.09B	3.29B
Revenue Growth	0.47%	21.43%	6.76%	53.35%	60.62%	13.36%	8.12%	6.38%
EPS	1.01	1.44	1.85	1.07	0.75	3.51	4.01	4.54
EPS Growth	-33.55%	42.57%	28.47%	-42.16%	-29.91%	367.80%	14.29%	13.14%
Forward PE	-	-	-	-	-	16.82	14.72	13.01
No. Analysts	-	-	-	-	-	17	17	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	3.1B	3.4B	3.7B
Avg	2.9B	3.1B	3.3B
Low	2.6B	2.8B	3.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	23.3%	19.9%	18.2%
Avg	13.4%	8.1%	6.4%
Low	4.0%	-2.2%	-4.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	3.67	4.50	4.99
Avg	3.51	4.01	4.54
Low	3.28	3.61	4.06

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	389.7%	28.4%	24.4%
Avg	367.8%	14.3%	13.1%
Low	337.7%	2.8%	1.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.